Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-01-04 @ 8:21 AM
Study NCT ID:
NCT03519256
Status:
TERMINATED
Last Update Posted:
2023-06-01
First Post:
2018-04-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-24
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-17
First Submit QC Date:
None
Study First Post Date:
2018-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-03
Results First Submit QC Date:
None
Results First Post Date:
2023-06-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-31
Last Update Post Date:
2023-06-01
Last Update Post Date Type:
ACTUAL